International Patient Summary Implementation Guide
2.0.0 - STU 2 International flag

International Patient Summary Implementation Guide, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ips/ and changes regularly. See the Directory of published versions

Table of Contents

Page standards status: Informative
.. 0 Table of Contents
... 1 Home
... 2 Changes
... 3 Copyrights
... 4 Datatypes
... 5 Design Conventions
... 6 Downloads
... 7 Examples
... 8 General Principles
... 9 Generation and Data Inclusion
... 10 Known Issues and Future Development
... 11 Privacy and Security Considerations
... 12 Profiles
... 13 Structure of the International Patient Summary
... 14 Terminology
... 15 Artifacts Summary
.... 15.1 IPS Server Capability Statement
.... 15.2 IPS Summary
.... 15.3 AllergyIntolerance (IPS)
.... 15.4 Bundle (IPS)
.... 15.5 Composition (IPS)
.... 15.6 Condition (IPS)
.... 15.7 Device (IPS)
.... 15.8 Device - Performer or Observer (IPS)
.... 15.9 DeviceUseStatement (IPS)
.... 15.10 DiagnosticReport (IPS)
.... 15.11 Flag - Alert (IPS)
.... 15.12 ImagingStudy (IPS)
.... 15.13 Immunization (IPS)
.... 15.14 Medication (IPS)
.... 15.15 MedicationRequest (IPS)
.... 15.16 MedicationStatement (IPS)
.... 15.17 Observation Pregnancy - Expected Delivery Date (IPS)
.... 15.18 Observation Pregnancy - Outcome (IPS)
.... 15.19 Observation Pregnancy - Status (IPS)
.... 15.20 Observation Results - Laboratory/Pathology (IPS)
.... 15.21 Observation Results - Radiology (IPS)
.... 15.22 Observation Social History - Alcohol Use (IPS)
.... 15.23 Observation Social History - Tobacco Use (IPS)
.... 15.24 Organization (IPS)
.... 15.25 Patient (IPS)
.... 15.26 Practitioner (IPS)
.... 15.27 PractitionerRole (IPS)
.... 15.28 Procedure (IPS)
.... 15.29 Specimen (IPS)
.... 15.30 Codeable Concept (IPS)
.... 15.31 Coding with translations
.... 15.32 Quantity (IPS)
.... 15.33 Range (IPS)
.... 15.34 Ratio (IPS)
.... 15.35 SimpleQuantity (IPS)
.... 15.36 Allergy Intolerance - IPS
.... 15.37 Allergy Reaction - IPS
.... 15.38 Body Site - IPS
.... 15.39 Current Smoking Status - IPS
.... 15.40 Diagnostics Report Status Codes - IPS
.... 15.41 Healthcare Professional Roles - IPS
.... 15.42 Imaging Study Status Codes - IPS
.... 15.43 Medical Devices - IPS
.... 15.44 Medications - example (IPS)
.... 15.45 Medications - IPS
.... 15.46 Medicine Active Substances - IPS
.... 15.47 Medicine Doseform - IPS
.... 15.48 Medicine Route of Administration - IPS
.... 15.49 Personal Relationship - IPS [Deprecated]
.... 15.50 Pregnancy Expected Delivery Date Method - IPS
.... 15.51 Pregnancy Outcome - IPS
.... 15.52 Pregnancy Status - IPS
.... 15.53 Problem Type (LOINC)
.... 15.54 Problem Type - IPS
.... 15.55 Problems - IPS
.... 15.56 Procedures - IPS
.... 15.57 Results Coded Values Laboratory/Pathology - IPS
.... 15.58 Results Laboratory/Pathology Observation - IPS
.... 15.59 Results Radiology Measurement Observation - IPS
.... 15.60 Results Radiology Observation - IPS
.... 15.61 Results Radiology Textual Observation - IPS
.... 15.62 Results Specimen Collection Method - IPS
.... 15.63 Results Specimen Type - IPS
.... 15.64 Results Status Codes - IPS
.... 15.65 Vaccine Target Diseases - IPS
.... 15.66 Vaccines - IPS
.... 15.67 Vaccines WHO ATC - IPS
.... 15.68 WHO ATC - IPS
.... 15.69 AllergyIntolerance - Multiple Codings
.... 15.70 AllergyIntolerance - No Known Allergies
.... 15.71 AllergyIntolerance - Resolved Allergy
.... 15.72 Bundle - IPS with Data
.... 15.73 Bundle - IPS with Required Sections and Immunization
.... 15.74 Bundle - Minimal Complete IPS
.... 15.75 Bundle - No Information in Required Sections
.... 15.76 Composition - Minimal Sections
.... 15.77 Condition - Acute Myeloid Leukemia
.... 15.78 Device - Device Observer
.... 15.79 Device - No Known Devices in Use
.... 15.80 DeviceUseStatement - No Known Devices in Use
.... 15.81 DiagnosticReport - Hemoglobin
.... 15.82 Flag - Alert of Patient Immunocompromised
.... 15.83 ImagingStudy - Referred DICOM Study
.... 15.84 Immunization - Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg)
.... 15.85 Medication - Simvastatin 40 MG Disintegrating Oral Tablet
.... 15.86 MedicationRequest - Simvastatin Request
.... 15.87 MedicationStatement - Ongoing Simvastatin Treatment
.... 15.88 Observation - Social History Alcohol Use
.... 15.89 Observation: estrogen receptor in tissue example
.... 15.90 Observation: hemoglobin example
.... 15.91 Observation: imaging Chest X-ray - PA and lateral, with additional sub-observation including numeric range
.... 15.92 Observation: imaging CT Abdomen W contrast IV
.... 15.93 Observation: imaging CT Abdomen W contrast IV, sub-observations
.... 15.94 Observation: pregnancy edd example
.... 15.95 Observation: pregnancy outcome example
.... 15.96 Observation: pregnancy status example
.... 15.97 Observation: serum creatinine example
.... 15.98 Observation: SH tobacco use example
.... 15.99 Observation: urine wbc range example
.... 15.100 Organization - Minimal Name Only
.... 15.101 Organization: example
.... 15.102 Organization: lab example
.... 15.103 Patient: female patient
.... 15.104 Patient: male patient
.... 15.105 Patient: minimal example
.... 15.106 Practitioner example
.... 15.107 PractitionerRole - Minimal
.... 15.108 Procedure: Surgical procedure
.... 15.109 Specimen: example